Abstract
Respiratory distress syndrome (RDS) causes significant hypoxia in extremely low birth weight (ELBW) infants. We report an ELBW infant with RDS and pulmonary hypertension whose hypoxia did not respond to inhaled nitric oxide but improved with inhaled prostacyclin. We propose that inhaled prostacyclin alleviated the hypoxia by stimulating surfactant secretion.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ehlen M, Wiebe B . Iloprost in persistent pulmonary hypertension of the newborn. Cardiol Young 2003; 13: 361–363.
De Jaegere AP, Van den Anker JN . Endotracheal instillation of prostacyclin in preterm infants with persistent pulmonary hypertension. Eur Respir J 1998; 12: 932–934.
Soditt V, Aring C, Groneck P . Improvement of oxygenation induced by aerosolized prostacyclin in a preterm infant with persistent pulmonary hypertension of the newborn. Intensive Care Med 1997; 23: 1275–1278.
Kelly LK, Porta NF, Goodman DM, Carrol CL, Steinborn RH . Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide. J Pediatr 2002; 141: 830–832.
Bindl L, Fahnenstich H, Peukert U . Aerosolised prostacyclin for pulmonary hypertension in neonates. Arch Dis Chid Fetal Neonatal Ed 1994; 71: F214–F216.
Kinsella JP, Abman SH . Inhaled nitric oxide therapy in children. Paediatr Respir Rev 2005; 6 (3): 190–198.
Beckman JS, Koppenol WH . Nitric oxide, superoxide, peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996; 271: C1424–C1427.
Haddad IY, Zhu S, Crow J, Barefield E, Gadilhe T, Matalon S . Inhibition of alveolar type II cell ATP and surfactant synthesis by nitric oxide. Am J of Physiol 1996; 270 (6 Part 1): L898–L906.
Ballard PL, Gonzales LW, Godinez RI, Godinez MH, Savani RC, McCurnin DC et al. Surfactant composition and function in a primate model of infant chronic lung disease: effects of inhaled nitric oxide. Pediatr Res 2006; 59: 157–162.
Peliowski A, Finer NN, Etches PC, Tierney AJ, Ryan AR . Inhaled Nitric Oxide for premature infants after prolonged rupture of membranes. J Pediatr 1995; 126: 450–453.
Skimming JW, Bender KA, Hutchinson AA, Drummond WH . Nitric Oxide inhalation in infants with respiratory distress syndrome. J Pediatr 1997; 130: 225–230.
Jones K, Higenbottam T, Wallwork J . Pulmonary vasodilation with prostacyclin in primary and secondary pulmonary hypertension. Chest 1989; 96 (4): 784–789.
Rose F, Zwick K, Ghofrani H, Sibelius U, Seeger W, Walmrath D et al. Prostacyclin enhances stretch-induced surfactant secretion in alveolar epithelial type II cells. Am J Respir Crit Care Med 1999; 160: 846–851.
De Luca D, Zecca E, Piastra M, Romagnoli C . Iloprost as ‘rescue’ therapy for pulmonary hypertension of the neonate. Pediatr Anesth 2007; 17: 394–395.
Acknowledgements
The authors would like to thank John Belmont, PhD, for his help with the manuscript especially with Figure 1 and Leoni Mattioli, MD, for his excellent suggestions.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Olmsted, K., Oluola, O., Parthiban, A. et al. Can inhaled prostacyclin stimulate surfactant in ELBW infants?. J Perinatol 27, 724–726 (2007). https://doi.org/10.1038/sj.jp.7211811
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jp.7211811